In this commentary, Michael J. Bloch, MD, writes about the risks and benefits of treating patients with mild to moderate hypertension during pregnancy and whether targeting blood pressure of less than...
In this commentary, Michael J Bloch, MD, writes about the use of acetaminophen for pain control in patients with hypertension and patients with an increased risk of cardiovascular events, including results...
In this article, Michael J Bloch, MD, discusses the usage of RAS-blocking agents, slowing the progression of end-stage renal disease, and reducing cardiovascular events in patients with advanced kidney...
In this article, Michael J. Bloch, MD, writes about the results of the recently published BrightHTN study, which examined the use of the investigational aldosterone synthase inhibitor baxdrostat in patients...
In this commentary, Michael J. Bloch, MD writes about controversies in the effect of dietary cholesterol and egg consumption on cardiovascular events and mortality.
In this article, Michael J. Bloch, MD, writes about orthostatic hypotension (OH), which is a frequent problem in patients with hypertension, including the approach to diagnosis and management of patients...
In this commentary, Michael J. Bloch, MD, writes about using nonpharmacological therapies, including endovascular renal denervation, to improve blood pressure control.
In this commentary, Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.
...
In this article, Michael J. Bloch, MD, writes about studies over the past 30 years that prove lower achieved blood pressure, including modest reductions in blood pressure, translates to lower cardiovascular...
In this commentary, Michael Bloch, MD, writes about the cardiovascular risk of exposure to ambient air pollution and how clinicians can play a role in mitigating exposure to reduce blood pressure and...
